Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2005 Nov;90(11):1138–1143. doi: 10.1136/adc.2005.071795

Assessment of hypoxia in children with cystic fibrosis

D Urquhart 1, H Montgomery 1, A Jaffe 1
PMCID: PMC1720198  PMID: 16243867

Full Text

The Full Text of this article is available as a PDF (102.0 KB).

Figure 1.

Figure 1

Open in a new tab

 Hypoxia and its purported effects on exercise: "the vicious circle".

Figure 2.

Figure 2

Open in a new tab

 Hypoxia, the innate immune system, and the CF lung.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auerbach H. S., Williams M., Kirkpatrick J. A., Colten H. R. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet. 1985 Sep 28;2(8457):686–688. doi: 10.1016/s0140-6736(85)92929-0. [DOI] [PubMed] [Google Scholar]
  2. Baeuerle P. A., Baltimore D. NF-kappa B: ten years after. Cell. 1996 Oct 4;87(1):13–20. doi: 10.1016/s0092-8674(00)81318-5. [DOI] [PubMed] [Google Scholar]
  3. Balfour-Lynn I. M., Primhak R. A., Shaw B. N. J. Home oxygen for children: who, how and when? Thorax. 2005 Jan;60(1):76–81. doi: 10.1136/thx.2004.031211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Balough K., McCubbin M., Weinberger M., Smits W., Ahrens R., Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol. 1995 Aug;20(2):63–70. doi: 10.1002/ppul.1950200203. [DOI] [PubMed] [Google Scholar]
  5. Bebök Z., Tousson A., Schwiebert L. M., Venglarik C. J. Improved oxygenation promotes CFTR maturation and trafficking in MDCK monolayers. Am J Physiol Cell Physiol. 2001 Jan;280(1):C135–C145. doi: 10.1152/ajpcell.2001.280.1.C135. [DOI] [PubMed] [Google Scholar]
  6. Betancourt M., Slade G., Dinwiddie R. Oxygen saturation in cystic fibrosis. Arch Dis Child. 1991 Sep;66(9):1075–1076. doi: 10.1136/adc.66.9.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Borriello Giorgia, Werner Erin, Roe Frank, Kim Aana M., Ehrlich Garth D., Stewart Philip S. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother. 2004 Jul;48(7):2659–2664. doi: 10.1128/AAC.48.7.2659-2664.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bradley S., Solin P., Wilson J., Johns D., Walters E. H., Naughton M. T. Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis. Chest. 1999 Sep;116(3):647–654. doi: 10.1378/chest.116.3.647. [DOI] [PubMed] [Google Scholar]
  9. Bright-Thomas Rowland J., Webb A. Kevin. The heart in cystic fibrosis. J R Soc Med. 2002;95 (Suppl 41):2–10. [PMC free article] [PubMed] [Google Scholar]
  10. Brightbill H. D., Modlin R. L. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology. 2000 Sep;101(1):1–10. doi: 10.1046/j.1365-2567.2000.00093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Buchdahl R. M., Babiker A., Bush A., Cramer D. Predicting hypoxaemia during flights in children with cystic fibrosis. Thorax. 2001 Nov;56(11):877–879. doi: 10.1136/thorax.56.11.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Burns J. L., Gibson R. L., McNamara S., Yim D., Emerson J., Rosenfeld M., Hiatt P., McCoy K., Castile R., Smith A. L. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2000 Dec 27;183(3):444–452. doi: 10.1086/318075. [DOI] [PubMed] [Google Scholar]
  13. Cantin A. Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med. 1995 Apr;151(4):939–941. doi: 10.1164/ajrccm.151.4.7697269. [DOI] [PubMed] [Google Scholar]
  14. Chmiel James F., Davis Pamela B. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir Res. 2003 Aug 27;4:8–8. doi: 10.1186/1465-9921-4-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Coffey M. J., FitzGerald M. X., McNicholas W. T. Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest. 1991 Sep;100(3):659–662. doi: 10.1378/chest.100.3.659. [DOI] [PubMed] [Google Scholar]
  16. Cramton S. E., Ulrich M., Götz F., Döring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun. 2001 Jun;69(6):4079–4085. doi: 10.1128/IAI.69.6.4079-4085.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Davis P. B., Drumm M., Konstan M. W. Cystic fibrosis. Am J Respir Crit Care Med. 1996 Nov;154(5):1229–1256. doi: 10.1164/ajrccm.154.5.8912731. [DOI] [PubMed] [Google Scholar]
  18. Deboeck G., Niset G., Lamotte M., Vachiéry J. L., Naeije R. Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur Respir J. 2004 May;23(5):747–751. doi: 10.1183/09031936.04.00111904. [DOI] [PubMed] [Google Scholar]
  19. Dinwiddie R., Madge S., Prasad S. A., Balfour-Lynn I. M. Oxygen therapy for cystic fibrosis. J R Soc Med. 1999;92 (Suppl 37):19–22. doi: 10.1177/014107689909237s04. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dobbin Catherine J., Bartlett Delwyn, Melehan Kerri, Grunstein Ronald R., Bye Peter T. P. The effect of infective exacerbations on sleep and neurobehavioral function in cystic fibrosis. Am J Respir Crit Care Med. 2005 Apr 14;172(1):99–104. doi: 10.1164/rccm.200409-1244OC. [DOI] [PubMed] [Google Scholar]
  21. Dormer R. L., Harris C. M., Clark Z., Pereira M. M. C., Doull I. J. M., Norez C., Becq F., McPherson M. A. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis. Thorax. 2005 Jan;60(1):55–59. doi: 10.1136/thx.2003.019778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Egan Marie E., Pearson Marilyn, Weiner Scott A., Rajendran Vanathy, Rubin Daniel, Glöckner-Pagel Judith, Canny Susan, Du Kai, Lukacs Gergely L., Caplan Michael J. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science. 2004 Apr 23;304(5670):600–602. doi: 10.1126/science.1093941. [DOI] [PubMed] [Google Scholar]
  23. Emtner Margareta, Porszasz Janos, Burns Mary, Somfay Attila, Casaburi Richard. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003 Jul 17;168(9):1034–1042. doi: 10.1164/rccm.200212-1525OC. [DOI] [PubMed] [Google Scholar]
  24. Fischer R., Lang S. M., Brückner K., Hoyer H-X, Meyer S., Griese M., Huber R. M. Lung function in adults with cystic fibrosis at altitude: impact on air travel. Eur Respir J. 2005 Apr;25(4):718–724. doi: 10.1183/09031936.05.10087304. [DOI] [PubMed] [Google Scholar]
  25. Frangolias D. D., Wilcox P. G. Predictability of oxygen desaturation during sleep in patients with cystic fibrosis : clinical, spirometric, and exercise parameters. Chest. 2001 Feb;119(2):434–441. doi: 10.1378/chest.119.2.434. [DOI] [PubMed] [Google Scholar]
  26. Fraser K. L., Tullis D. E., Sasson Z., Hyland R. H., Thornley K. S., Hanly P. J. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest. 1999 May;115(5):1321–1328. doi: 10.1378/chest.115.5.1321. [DOI] [PubMed] [Google Scholar]
  27. Gan W. Q., Man S. F. P., Senthilselvan A., Sin D. D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004 Jul;59(7):574–580. doi: 10.1136/thx.2003.019588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J. 1997 Sep;10(9):1999–2003. doi: 10.1183/09031936.97.10091999. [DOI] [PubMed] [Google Scholar]
  29. Hajjar Adeline M., Ernst Robert K., Tsai Jeff H., Wilson Christopher B., Miller Samuel I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol. 2002 Mar 25;3(4):354–359. doi: 10.1038/ni777. [DOI] [PubMed] [Google Scholar]
  30. Hoo Guy W. Soo. Nonpharmacologic adjuncts to training during pulmonary rehabilitation: the role of supplemental oxygen and noninvasive ventilation. J Rehabil Res Dev. 2003 Sep-Oct;40(5 Suppl 2):81–97. doi: 10.1682/jrrd.2003.10.0081. [DOI] [PubMed] [Google Scholar]
  31. Horowitz S. Pathways to cell death in hyperoxia. Chest. 1999 Jul;116(1 Suppl):64S–67S. doi: 10.1378/chest.116.suppl_1.64s. [DOI] [PubMed] [Google Scholar]
  32. Hunter Vanessa. The daily grind and how to stay sane as a mother of two children with cystic fibrosis. J R Soc Med. 2003;96 (Suppl 43):51–56. [PMC free article] [PubMed] [Google Scholar]
  33. Klijn Peter H. C., Oudshoorn Annemarie, van der Ent Cornelis K., van der Net Janjaap, Kimpen Jan L., Helders Paul J. M. Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest. 2004 Apr;125(4):1299–1305. doi: 10.1378/chest.125.4.1299. [DOI] [PubMed] [Google Scholar]
  34. Konstan M. W., Byard P. J., Hoppel C. L., Davis P. B. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995 Mar 30;332(13):848–854. doi: 10.1056/NEJM199503303321303. [DOI] [PubMed] [Google Scholar]
  35. Kusenbach G., Wieching R., Barker M., Hoffmann U., Essfeld D. Effects of hyperoxia on oxygen uptake kinetics in cystic fibrosis patients as determined by pseudo-random binary sequence exercise. Eur J Appl Physiol Occup Physiol. 1999 Jan;79(2):192–196. doi: 10.1007/s004210050494. [DOI] [PubMed] [Google Scholar]
  36. Laubscher B. Home oxygen therapy: beware of birthday cakes. Arch Dis Child. 2003 Dec;88(12):1125–1125. doi: 10.1136/adc.88.12.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mairbäurl Heimo, Schwöbel Florian, Höschele Sabine, Maggiorini Marco, Gibbs Simon, Swenson Erik R., Bärtsch Peter. Altered ion transporter expression in bronchial epithelium in mountaineers with high-altitude pulmonary edema. J Appl Physiol (1985) 2003 Nov;95(5):1843–1850. doi: 10.1152/japplphysiol.01156.2002. [DOI] [PubMed] [Google Scholar]
  38. Marcus C. L., Bader D., Stabile M. W., Wang C. I., Osher A. B., Keens T. G. Supplemental oxygen and exercise performance in patients with cystic fibrosis with severe pulmonary disease. Chest. 1992 Jan;101(1):52–57. doi: 10.1378/chest.101.1.52. [DOI] [PubMed] [Google Scholar]
  39. McKone E. F., Barry S. C., FitzGerald M. X., Gallagher C. G. The role of supplemental oxygen during submaximal exercise in patients with cystic fibrosis. Eur Respir J. 2002 Jul;20(1):134–142. doi: 10.1183/09031936.02.00492001. [DOI] [PubMed] [Google Scholar]
  40. Milross M. A., Piper A. J., Norman M., Willson G. N., Grunstein R. R., Sullivan C. E., Bye P. T. Predicting sleep-disordered breathing in patients with cystic fibrosis. Chest. 2001 Oct;120(4):1239–1245. doi: 10.1378/chest.120.4.1239. [DOI] [PubMed] [Google Scholar]
  41. Milross Maree A., Piper Amanda J., Norman Mark, Dobbin Catherine J., Grunstein Ronald R., Sullivan Colin E., Bye Peter T. P. Subjective sleep quality in cystic fibrosis. Sleep Med. 2002 May;3(3):205–212. doi: 10.1016/s1389-9457(01)00157-5. [DOI] [PubMed] [Google Scholar]
  42. Morello J. P., Petäjä-Repo U. E., Bichet D. G., Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci. 2000 Dec;21(12):466–469. doi: 10.1016/s0165-6147(00)01575-3. [DOI] [PubMed] [Google Scholar]
  43. Muhlebach M. S., Stewart P. W., Leigh M. W., Noah T. L. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med. 1999 Jul;160(1):186–191. doi: 10.1164/ajrccm.160.1.9808096. [DOI] [PubMed] [Google Scholar]
  44. Narang I., Pike S., Rosenthal M., Balfour-Lynn I. M., Bush A. Three-minute step test to assess exercise capacity in children with cystic fibrosis with mild lung disease. Pediatr Pulmonol. 2003 Feb;35(2):108–113. doi: 10.1002/ppul.10213. [DOI] [PubMed] [Google Scholar]
  45. Noah T. L., Black H. R., Cheng P. W., Wood R. E., Leigh M. W. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis. 1997 Mar;175(3):638–647. doi: 10.1093/infdis/175.3.638. [DOI] [PubMed] [Google Scholar]
  46. Nourry Cédric, Fabre Claudine, Bart Frédéric, Grosbois Jean-Marie, Berthoin Serge, Mucci Patrick. Evidence of exercise-induced arterial hypoxemia in prepubescent trained children. Pediatr Res. 2004 Jan 22;55(4):674–681. doi: 10.1203/01.PDR.0000114481.58902.FB. [DOI] [PubMed] [Google Scholar]
  47. Oades P. J., Buchdahl R. M., Bush A. Prediction of hypoxaemia at high altitude in children with cystic fibrosis. BMJ. 1994 Jan 1;308(6920):15–18. doi: 10.1136/bmj.308.6920.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ryland D., Reid L. The pulmonary circulation in cystic fibrosis. Thorax. 1975 Jun;30(3):285–292. doi: 10.1136/thx.30.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Soubani A. O. Noninvasive monitoring of oxygen and carbon dioxide. Am J Emerg Med. 2001 Mar;19(2):141–146. doi: 10.1053/ajem.2001.21353. [DOI] [PubMed] [Google Scholar]
  50. Spier S., Rivlin J., Hughes D., Levison H. The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis. Am Rev Respir Dis. 1984 May;129(5):712–718. doi: 10.1164/arrd.1984.129.5.712. [DOI] [PubMed] [Google Scholar]
  51. Ten Vadim S., Pinsky David J. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care. 2002 Jun;8(3):242–250. doi: 10.1097/00075198-200206000-00008. [DOI] [PubMed] [Google Scholar]
  52. Tepper R. S., Skatrud J. B., Dempsey J. A. Ventilation and oxygenation changes during sleep in cystic fibrosis. Chest. 1983 Oct;84(4):388–393. doi: 10.1378/chest.84.4.388. [DOI] [PubMed] [Google Scholar]
  53. Timms R. M., Khaja F. U., Williams G. W. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med. 1985 Jan;102(1):29–36. doi: 10.7326/0003-4819-102-1-29. [DOI] [PubMed] [Google Scholar]
  54. Urschitz Michael S., Wolff Judith, Von Einem Volker, Urschitz-Duprat Pilar M., Schlaud Martin, Poets Christian F. Reference values for nocturnal home pulse oximetry during sleep in primary school children. Chest. 2003 Jan;123(1):96–101. doi: 10.1378/chest.123.1.96. [DOI] [PubMed] [Google Scholar]
  55. Versteegh F. G., Bogaard J. M., Raatgever J. W., Stam H., Neijens H. J., Kerrebijn K. F. Relationship between airway obstruction, desaturation during exercise and nocturnal hypoxaemia in cystic fibrosis patients. Eur Respir J. 1990 Jan;3(1):68–73. [PubMed] [Google Scholar]
  56. Worlitzsch Dieter, Tarran Robert, Ulrich Martina, Schwab Ute, Cekici Aynur, Meyer Keith C., Birrer Peter, Bellon Gabriel, Berger Jürgen, Weiss Tilo. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002 Feb;109(3):317–325. doi: 10.1172/JCI13870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Yankaskas James R., Marshall Bruce C., Sufian Beth, Simon Richard H., Rodman David. Cystic fibrosis adult care: consensus conference report. Chest. 2004 Jan;125(1 Suppl):1S–39S. doi: 10.1378/chest.125.1_suppl.1s. [DOI] [PubMed] [Google Scholar]
  58. Yildizdaş D., Yapicioğlu H., Yilmaz H. L., Sertdemir Y. Correlation of simultaneously obtained capillary, venous, and arterial blood gases of patients in a paediatric intensive care unit. Arch Dis Child. 2004 Feb;89(2):176–180. doi: 10.1136/adc.2002.016261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zinman R., Corey M., Coates A. L., Canny G. J., Connolly J., Levison H., Beaudry P. H. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr. 1989 Mar;114(3):368–377. doi: 10.1016/s0022-3476(89)80553-0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES